Nuvama cuts target price on Alkem Lab: Find out why?

Nuvama Institutional Equities cut the target price on Alkem Laboratories by 3.5% to Rs 5,840 from Rs 6,053 as the brokerage house sees a slowdown in acute business. It retained its ‘Hold’ call on the stock. It also slashed the earnings per share estimates by 3% for FY26 and 2% for FY27. It further cut the return on equity estimate to 17% in FY27. 

The brokerage firm said that the company’s domestic business declined sequentially, which reflects a slowdown in the acute business. Adding, the impact of no price hike in the NLEM portfolio, which makes up 30% of domestic revenue. 

Alkem Laboratories’ domestic business in the third quarter of the current fiscal year dropped 4% sequentially to Rs 2,400 crore. However, it grew 6% year-on-year. The domestic business missed Nuvama’s estimates. 

Also Read HDFC AMC shares jump 5%. Here are 4 reasons why brokerages are bullish Nomura maintains Buy on ITC. Here are 3 reasons why… ‘US to deport 7.25 lakh Indians’, Rajiv Shukla shares key data, ‘they were earning good, suddenly turned…’ Why is the stock market falling today? Here are 3 reasons…

Not just domestic business, but international business also faced some heat. The US exports contracted 7% YoY while the international exports contracted 14% YoY. However, the brokerage firm thinks that it may return to normal levels with growth in the domestic acute and US generics. 

“We note Alkem’s gross margin in 9MFY25 is attractive; however, this may not sustain in FY26E with growth in domestic acute and US generics business. We think cost optimisation is necessary to expand EBITDA margin,” said Nuvama in a research note. 

Further, it said that acquisitions have a small quantum as the company recently acquired Bombay Ortho and Adroit Biomed, which made a combined revenue of Rs 60 crore for FY24, 0.5% of consolidated revenue. “We note, that under new management, Alkem is making some hard decisions (divestment/M&A), even though the quantum is very small for now,” Nuvama said. 

Alkem Laboratories in Q3

The company’s consolidated net profit rose 6% YoY to Rs 641 crore from Rs 604 crore in Q3 FY24. Sequentially, profit fell almost 9% from 702 crore in the previous quarter of the same financial year. Its total income for the quarter stood at Rs 3,467 crore,

 » Read More

Related Articles

Stock Market Live Updates: Sensex, Nifty set to open higher on positive cues

Go to Live UpdatesSensex Nifty Today | Stock Market Live Updates: Early trends from Gift Nifty indicates a positive start for the markets today. Asian markets are also trading higher, with key indices in Japan and South Korea opening on a positive note. Meanwhile, Indian stock markets have reopened after a long weekend and the

How will markets open today? Fed meeting, Trump tariffs & 7 more cues to watch

After a long weekend on account of Holi, the Indian stock markets are set to resume trading today, March 17. But will the break bring fresh momentum, or will investors return to a cautious start? Early trends from Gift Nifty indicate a positive opening. From Wall Street’s performance to key economic announcements, several factors will

Stocks To Watch: From IndusInd Bank to Infosys- Here’s a list of 11 stocks in news today

After an extended break due to the Holi holiday and the weekend, the stock market is set to resume trading with plenty of action on the horizon today, March 17. With three days of global market movements, company updates, and economic cues piling up, investors will have a lot to factor in as the trading

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Stock Market Live Updates: Sensex, Nifty set to open higher on positive cues

Go to Live UpdatesSensex Nifty Today | Stock Market Live Updates: Early trends from Gift Nifty indicates a positive start for the markets today. Asian markets are also trading higher, with key indices in Japan and South Korea opening on a positive note. Meanwhile, Indian stock markets have reopened after a long weekend and the

How will markets open today? Fed meeting, Trump tariffs & 7 more cues to watch

After a long weekend on account of Holi, the Indian stock markets are set to resume trading today, March 17. But will the break bring fresh momentum, or will investors return to a cautious start? Early trends from Gift Nifty indicate a positive opening. From Wall Street’s performance to key economic announcements, several factors will

Stocks To Watch: From IndusInd Bank to Infosys- Here’s a list of 11 stocks in news today

After an extended break due to the Holi holiday and the weekend, the stock market is set to resume trading with plenty of action on the horizon today, March 17. With three days of global market movements, company updates, and economic cues piling up, investors will have a lot to factor in as the trading

Market Outlook: Nifty at inflection point; defence stocks headed higher?

By Anand James One point at the start of last week was how strong an offensive could the bears launch. At that point, we were just coming off a sub 25 RSI level, which had historically favoured a bounce back. But such moves also held a strong chance of fizzling out quickly. This is why

Rapido plans to undercut Swiggy, Zomato duopoly

Ride-hailing platform Rapido is in advanced talks with restaurants and industry associations across four major metro cities to challenge the dominance of Swiggy and Zomato, which together command an estimated 95% market share. The move comes at a time when restaurants have been voicing growing concerns over high commission rates and potential conflicts of interest following